Results 91 to 100 of about 226,631 (261)

Real‐world incidence and clinical characteristics of intraocular inflammation following intravitreal faricimab therapy: A safety study

Acta Ophthalmologica, EarlyView.
Abstract Purpose To estimate the real‐world incidence of intraocular inflammation (IOI) following intravitreal faricimab injections at a large, highly specialized tertiary centre. Methods Single‐centre, retrospective cohort study with chart review using an electronic injection database and electronic medical records from November 2023 to August 2024 ...
Miklos Schneider, Leyla Turan, Farah Arif, Jakob Bjerager, Oliver Niels Klefter, Carsten Faber, Yousif Subhi, Javad Nouri Hajari   +7 more
wiley   +1 more source

The Difference Of Visual Acuity And Macular Thickness Post Bevacizumab Therapy In Secondary Macular Edema Retinal Vein Occlusion

Journal of Agromedicine and Medical Sciences (AMS), 2018
Retinal vein occlusion is the second most common cause of blindness in retinal vascular disease after diabetic retinopathy and may lead to complications of macular edema.
Citra Rahmadani, Nur Khoma Fatmawati, Rahmat Bakhtiar   +2 more
doaj   +1 more source

The Relationship Between Macular Cyst Formation and Ischemia in Diabetic Macular Edema

, 2019
To evaluate the relationship between cyst characteristics and macular and peripheral ischemia in diabetic macular edema (DME)
Şengül Özdek, Nuriye Gökçen Yalçın, Özdek, Şengül, Yalçın, Nuriye Gökçen   +3 more
core   +1 more source

Impact of delayed appointments on treatment outcomes in neovascular macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the real‐world visual outcomes of anti‐vascular endothelial growth factor (anti‐VEGF) therapy, the frequency of delayed appointments and the relationship between delays and visual outcomes in patients with neovascular age‐related macular degeneration (nAMD).
Petri Purola, Pekko Hujanen, Hannu Uusitalo, Hannele Uusitalo‐Järvinen   +3 more
wiley   +1 more source

Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines

Indian Journal of Ophthalmology, 2016
The purpose of the study was to review the current evidence and design a diabetic macular edema (DME) management guideline specific for India. The published DME guidelines from different organizations and publications were weighed against the practice ...
Taraprasad Das, Ajay Aurora, Jay Chhablani, Anantharaman Giridhar, Atul Kumar, Rajiv Raman, Manish Nagpal, Raja Narayanan, Sundaram Natarajan, Kim Ramasamay, Mudit Tyagi, Lalit Verma   +11 more
doaj   +1 more source

Primary treatment of diabetic macular edema

, 2009
Tushar M Ranchod, Stuart L FineScheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USAAbstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans.
Stuart L Fine, Tushar M Ranchod
core  

Wyburn‐Mason Syndrome: A Case Report

The Kaohsiung Journal of Medical Sciences, EarlyView.
Yu‐Wen Wang, Chen‐Lu Pei, Jian‐Yang Gong   +2 more
wiley   +1 more source

Visual acuity is reduced with increasing central retinal thickness, but also with higher age and female sex in diabetic macular oedema

Acta Ophthalmologica, EarlyView.
Abstract Introduction The increasing number of patients with diabetes has increased the incidence of diabetic macular oedema (DME) with the accompanying risk of developing visual loss. The purpose of the present study was to describe the contributions of increased central retinal thickness (CRT) and other risk factors to the reduction in visual acuity ...
Signe Krejberg Jeppesen, Toke Bek
wiley   +1 more source

Update in treatment of uveitic macular edema

, 2019
Spyridon Koronis,1 Panagiotis Stavrakas,2 Miltiadis Balidis,1 Nikolaos Kozeis,1 Paris G Tranos1 1Ophthalmica Eye Institute, Thessaloniki, Greece; 2Department of Ophthalmology, Attikon University Hospital, Athens, Greece Abstract: Macular edema (ME ...
Koronis S, Tranos PG, Balidis M, Stavrakas P, Kozeis N   +4 more
core  

The m.14484T>C MT‐ND6 Mutation Presenting with a Hereditary Spastic‐Paraparesis Phenotype

Movement Disorders Clinical Practice, EarlyView.
Gabriel Amorelli, Christelle Nilles, Gerald Pfeffer, Matthew Joel, Davide Martino   +4 more
wiley   +1 more source